Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival. Issue 2 (April 2015)

• Record Type: Journal Article
• Authors: Nagle, Christina M.; Ibiebele, Torukiri I.; DeFazio, Anna; Protani, Melinda M.; Webb, Penelope M.; on behalf of the Australian Ovarian Cancer Study Group
• Is Part Of: Cancer epidemiology. Volume 39:Issue 2(2015)
• Page Start: 196
• Page End: 199
• Publication Date: 2015-04
• Subjects: Cancer -- Epidemiology -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Diagnosis -- Periodicals; Carcinogenesis -- Periodicals; 616.994005
• DOI: 10.1016/j.canep.2014.12.010
• Languages: English
• ISSNs: 1877-7821

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">We have studied, for the first time, associations between aspirin, NSAIDs, acetaminophen and ovarian cancer survival.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">We investigated use in the 5 years preceding ovarian cancer diagnosis among 1305 women.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">We found uniformly inverse, but non-significant, hazard ratios for users of aspirin, NSAIDs and acetaminophen.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Associations did not differ by histologic subtype or stage at diagnosis.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">Results provide no strong evidence that use of aspirin or NSAIDs are associated with improved survival.</p> </list-item> </list> </p> </sec> </abstract>